RA Capital Management - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 105 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
RA Capital Management ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$16,360,000
+0.3%
1,000,0000.0%0.36%
+24.0%
Q4 2021$16,310,0001,000,0000.29%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 3,168,388$50,251,0005.05%
ATP Life Science Ventures, L.P. 4,028,937$63,859,0004.93%
Affinity Asset Advisors, LLC 150,000$2,379,0001.26%
Altium Capital Management LP 205,799$3,264,0001.22%
EcoR1 Capital, LLC 1,250,001$19,825,0001.07%
Vivo Capital, LLC 1,206,266$19,131,0000.85%
Marquette Asset Management, LLC 182,036$2,887,0000.66%
Monashee Investment Management LLC 272,949$4,329,0000.57%
Ally Bridge Group (NY) LLC 199,600$3,166,0000.54%
Rubric Capital Management LP 325,863$5,168,0000.38%
View complete list of CHINOOK THERAPEUTICS INC shareholders